These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 9661088)

  • 1. The use of flumazenil in the anxious and benzodiazepine-dependent ECT patient.
    Krystal AD; Watts BV; Weiner RD; Moore S; Steffens DC; Lindahl V
    J ECT; 1998 Mar; 14(1):5-14. PubMed ID: 9661088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous flumazenil following prolonged exposure to lormetazepam in humans: lack of precipitated withdrawal.
    Gerra G; Giucasto G; Zaimovic A; Fertonani G; Chittolini B; Avanzini P; Caccavari R; Delsignore R
    Int Clin Psychopharmacol; 1996 Jun; 11(2):81-8. PubMed ID: 8803645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flumazenil pretreatment in benzodiazepine-free patients: a novel method for managing declining ECT seizure quality.
    Yi J; Torres J; Azner Y; Vaidya P; Schiavi A; Reti IM
    J ECT; 2012 Sep; 28(3):185-9. PubMed ID: 22513511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance.
    Geretsegger C; Nickel M; Judendorfer B; Rochowanski E; Novak E; Aichhorn W
    J ECT; 2007 Dec; 23(4):239-43. PubMed ID: 18090696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flumazenil reversal of benzodiazepine-induced sedation for a patient with severe pre-ECT anxiety.
    Bailine SH; Safferman A; Vital-Herne J; Bernstein S
    Convuls Ther; 1994 Mar; 10(1):65-8. PubMed ID: 7914463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot pharmacokinetic-pharmacodynamic study of benzodiazepine antagonism by flumazenil and aminophylline.
    Bonfiglio MF; Fisher-Katz LE; Saltis LM; Traeger SM; Martin BR; Nackes NA; Perkins TA
    Pharmacotherapy; 1996; 16(6):1166-72. PubMed ID: 8947991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dependence on benzodiazepine and treatment of withdrawal syndrome].
    Sep-Kowalikowa B; Czucha M
    Psychiatr Pol; 2002; 36(6 Suppl):347-57. PubMed ID: 12647459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Benzodiazepine withdrawal with carbamazepine].
    Kaendler SH; Volk S; Pflug B
    Nervenarzt; 1996 May; 67(5):381-6. PubMed ID: 9005346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of flumazenil in the treatment of benzodiazepine dependence: physiological and psychological profiles.
    Hood S; O'Neil G; Hulse G
    J Psychopharmacol; 2009 Jun; 23(4):401-9. PubMed ID: 19164495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of aggression during benzodiazepine withdrawal: effects of flumazenil.
    Saxon L; Borg S; Hiltunen AJ
    Pharmacol Biochem Behav; 2010 Aug; 96(2):148-51. PubMed ID: 20451546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exceptionally high seizure threshold: ECT device limitations.
    Lisanby SH; Devanand DP; Nobler MS; Prudic J; Mullen L; Sackeim HA
    Convuls Ther; 1996 Sep; 12(3):156-64. PubMed ID: 8872404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal nonconvulsive seizures during detoxification for benzodiazepine abuse.
    Albiero A; Brigo F; Faccini M; Casari R; Quaglio G; Storti M; Fiaschi A; Bongiovanni LG; Lugoboni F
    Epilepsy Behav; 2012 Feb; 23(2):168-70. PubMed ID: 22200495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing seizure duration and number of seizures applied in unilateral electroconvulsive therapy. Anaesthetics and benzodiazepines.
    Strömgren LS; Dahl J; Fjeldborg N; Thomsen A
    Acta Psychiatr Scand; 1980 Aug; 62(2):158-65. PubMed ID: 6110313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of flumazenil-augmentation on microsleep and mood in depressed patients during partial sleep deprivation.
    Hemmeter U; Hatzinger M; Brand S; Holsboer-Trachsler E
    J Psychiatr Res; 2007 Nov; 41(10):876-84. PubMed ID: 16978648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A risk-benefit assessment of flumazenil in the management of benzodiazepine overdose.
    Weinbroum AA; Flaishon R; Sorkine P; Szold O; Rudick V
    Drug Saf; 1997 Sep; 17(3):181-96. PubMed ID: 9306053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study.
    Gerra G; Zaimovic A; Giusti F; Moi G; Brewer C
    Addict Biol; 2002 Oct; 7(4):385-95. PubMed ID: 14578014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
    Baghai TC; Marcuse A; Brosch M; Schüle C; Eser D; Nothdurfter C; Steng Y; Noack I; Pietschmann K; Möller HJ; Rupprecht R
    World J Biol Psychiatry; 2006; 7(2):82-90. PubMed ID: 16684680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualized continuation electroconvulsive therapy and medication as a bridge to relapse prevention after an index course of electroconvulsive therapy in severe mood disorders: a naturalistic 3-year cohort study.
    Odeberg H; Rodriguez-Silva B; Salander P; Mårtensson B
    J ECT; 2008 Sep; 24(3):183-90. PubMed ID: 18695624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flumazenil in alcohol withdrawal.
    Nutt D; Glue P; Wilson S; Groves S; Coupland N; Bailey J
    Alcohol Alcohol Suppl; 1993; 2():337-41. PubMed ID: 7748321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.